Spinal GABAergic Mechanisms in the Effects of Spinal Cord Stimulation in a Rodent Model of Neuropathic Pain: Is GABA Synthesis Involved?
| Autor: | C. Ultenius, Bengt Linderoth, Björn A. Meyerson, Paoyan Lin, Zhiyang Song |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Male
Pain Threshold medicine.medical_specialty Glutamate decarboxylase Inhibitory postsynaptic potential gamma-Aminobutyric acid Internal medicine Threshold of pain medicine Animals GABAergic Neurons Rats Wistar gamma-Aminobutyric Acid Pain Measurement Analysis of Variance Spinal Cord Stimulation integumentary system Glutamate Decarboxylase business.industry General Medicine Spinal cord Rats Disease Models Animal Anesthesiology and Pain Medicine medicine.anatomical_structure Endocrinology Gene Expression Regulation Spinal Cord nervous system Neurology Hyperalgesia Neuropathic pain Neuralgia GABAergic Neurology (clinical) medicine.symptom business tissues Neuroscience medicine.drug |
| Zdroj: | Neuromodulation: Technology at the Neural Interface. 16:114-120 |
| ISSN: | 1094-7159 |
| Popis: | Objectives The effects of spinal cord stimulation (SCS) on the spinal γ-amino butyric acid (GABA) system have previously been studied in animal models of neuropathic pain. These studies, confirming the pivotal role of segmental GABA actions for the efficacy of SCS, have led to the question if the disturbance of the GABA inhibitory system as demonstrated both in basal and clinical studies also encompasses malfunction of the GABA synthesis. Methods Rat models of neuropathic pain were submitted to SCS applied with “clinical SCS parameters.” The levels of the GABA-synthesizing enzymes, glutamic acid decarboxylase (GAD) 65 and GAD 67, in the spinal dorsal horns (DHs) were analyzed using Western blot and immunohistochemistry comparing responders and nonresponders to SCS, with and without SCS, as well as controls. Results There were no significant differences in general DH GAD levels between hypersensitive, nonhypersensitive, and intact control animals. Although SCS did not significantly influence these levels, there was a significant local augmentation of GAD 65 expression in lamina II in SCS responders subjected to SCS immediately prior to tissue collection as compared with SCS nonresponders. Conclusions Although GABAergic mechanisms are closely related to the effects of SCS, the presence of neuropathic signs and their suppression by SCS are not associated with changes of the general levels of the spinal DH GABA-synthesizing enzymes. However, in SCS responding animals, there was a significant increased expression of GAD 65 in lamina II, presumably reflecting an augmented GABA synthesis following SCS. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect